瑞慈醫療(01526.HK)發盈喜，預料截至2023年12月31日止年度溢利將按年增長，介乎3.5億至3.9億元人民幣，對比2022年度溢利為近2.91億元人民幣，主要由於期內體檢業務強勁復甦並實現進一步增長，帶動全年收入提升。
《盈利預喜》瑞慈醫療(01526.HK)料上年度溢利增至介乎3.5億至3.9億人幣
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.